Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
Cerebral vasculopathy is associated with severe vascular manifestations in systemic sclerosis
Journal of Rheumatology, 07/02/09
Terrier B et al. – Findings suggest that severe cerebral vasculopathy is associated with severe vascular manifestations in systemic sclerosis (SSc) patients. These patients should undergo neuroradiological imaging assessment of brain involvement.
Methods- An investigation of the brain involvement in pts with SSc
- 63 pts; 30 (47.6%) with limited cutaneous and 27 (42.9%) with diffuse cutaneous SSc
- 41 pts underwent CT scan and MRI of brain, 11 pts only CT scan, and 11 pts only MRI
- Cerebral vasculopathy on MRI and CT scan was defined as: absent or mild, moderate, or severe on a 4-point scale (0-3)
- Cerebral vasculopathy was identified on CT scan in 22 pts and on MRI in 38 pts
- Pts with severe cerebral vasculopathy seen on MRI were more likely to have pulmonary arterial hypertension (PAH) and showed a tendency to have scleroderma renal crisis
- A similar association was found between severe cerebral vasculopathy seen on CT scan and PAH or SRC
- After adjusting for age and hypertension, severe cerebral vasculopathy was still associated with increased risk of severe vascular manifestations
Today in Connective Tissue Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Nephrogenic systemic fibrosis
Current Opinion in Rheumatology, 11/04/09
Effect of Sildenafil on digital ulcers in systemic sclerosis - analysis from a single centre pilot study
Annals of Rheumatic Diseases, 11/23/09
Dabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblasts
Arthritis & Rheumatism, 11/11/09
Sponsor
Article Search
Sponsor


See Latest Articles


